T cells and their receptors (TCRs) play a critical role in adaptive immune responses. As a result, the modulation of TCR signaling pathways is highly relevant to many therapeutic areas, including cancer immunotherapy and adoptive cell therapy.
The discovery and development of small molecules and antibodies targeting T cell function, as well as T cell-based cell therapies and cell manufacturing, require assays to rapidly and reliably profile T cell activation and cell health.
In this app note, discover how phenotypic screening addresses these needs, with a single assay providing rapid, optimized monitoring of:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out ourPrivacy Policy